Pernix Pharma Ltd., based in Zalaegerszeg, is more than just a successful company: continuous growth, dedication, and precision have made it one of the leading players in the Hungarian pharmaceutical industry. With the support of European Union funding, the company has taken modernization and capacity expansion to a new level.
Founded in 2000, Pernix Pharma initially operated as a medium-sized enterprise, already implementing GMP (Good Manufacturing Practice) standards and a customer-focused, flexible operational approach. The company quickly proved that regulated manufacturing processes combined with transparent quality control systems result in excellent product quality. Since then, Pernix Pharma’s growth has been steady, successfully adapting to the unique needs and business goals of its clients. Today, its human and veterinary pharmaceuticals are not only available in Hungary but are also present in more than 11 European countries.
Over the years, the company’s manufacturing portfolio has expanded significantly, and today it has extensive expertise in producing solid, soft, and liquid dosage forms, as well as aerosols. Like many other companies, Pernix Pharma faced significant challenges during the COVID-19 pandemic. The key to recovery was maintaining and strengthening competitiveness. The completed development project enabled a complete overhaul of outdated machinery and the introduction of EU GMP-compliant manufacturing equipment.
During the modernization of laboratory and production equipment, the company also invested in advanced analytical instruments, making testing processes faster and more accurate. This has further enhanced product reliability and quality stability.
The upgraded equipment has not only modernized production technology but also contributed significantly to preserving jobs, improving cost efficiency and sustainability, increasing production capacity, and enhancing working conditions.
The development was implemented from EU funding in the project GINOP-1.2.8-20-2020-00568 under the Economic Development and Innovation Operational Programme Plus.
Find out more about the project in the Project Finder: Details
